Cargando…

Factors Influencing Retention in Care after Starting Antiretroviral Therapy in a Rural South African Programme

INTRODUCTION: The prognosis of patients with HIV in Africa has improved with the widespread use of antiretroviral therapy (ART) but these successes are threatened by low rates of long-term retention in care. There are limited data on predictors of retention in care, particularly from rural sites. ME...

Descripción completa

Detalles Bibliográficos
Autores principales:	Boyles, Tom H., Wilkinson, Lynne S., Leisegang, Rory, Maartens, Gary
Formato:	Texto
Lenguaje:	English
Publicado:	Public Library of Science 2011
Materias:	Research Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3086905/ https://www.ncbi.nlm.nih.gov/pubmed/21559280 http://dx.doi.org/10.1371/journal.pone.0019201

Ejemplares similares

Early and Late Direct Costs in a Southern African Antiretroviral Treatment Programme: A Retrospective Cohort Analysis
por: Leisegang, Rory, et al.
Publicado: (2009)

Improving the evidence base of Markov models used to estimate the costs of scaling up antiretroviral programmes in resource-limited settings
por: Leisegang, Rory, et al.
Publicado: (2010)

Third-line antiretroviral therapy in Africa: effectiveness in a Southern African retrospective cohort study
por: Meintjes, Graeme, et al.
Publicado: (2015)

A Novel Markov Model Projecting Costs and Outcomes of Providing Antiretroviral Therapy to Public Patients in Private Practices versus Public Clinics in South Africa
por: Leisegang, Rory, et al.
Publicado: (2013)

Retention and predictors of attrition among patients who started antiretroviral therapy in Zimbabwe’s national antiretroviral therapy programme between 2012 and 2015
por: Makurumidze, Richard, et al.
Publicado: (2020)

Early severe morbidity and resource utilization in South African adults on antiretroviral therapy
por: de Cherif, Teresa K Smith, et al.
Publicado: (2009)

Short term adherence tool predicts failure on second line protease inhibitor-based antiretroviral therapy: an observational cohort study
por: Court, Richard, et al.
Publicado: (2014)

Renal impairment in a rural African antiretroviral programme
por: Franey, Cara, et al.
Publicado: (2009)

Antiretroviral Therapy, Especially Efavirenz, Is Associated with Low Bone Mineral Density in HIV-Infected South Africans
por: Dave, Joel A., et al.
Publicado: (2015)

Risk Factors for Incident Diabetes in a Cohort Taking First-Line Nonnucleoside Reverse Transcriptase Inhibitor-Based Antiretroviral Therapy
por: Karamchand, Sumanth, et al.
Publicado: (2016)

Retention in care and factors critical for effectively implementing antiretroviral adherence clubs in a rural district in South Africa
por: Bock, Peter, et al.
Publicado: (2019)

Changes in blood pressure, glucose levels, insulin secretion and anthropometry after long term exposure to antiretroviral therapy in South African women
por: Abrahams, Zulfa, et al.
Publicado: (2015)

Third-Line Antiretroviral Therapy Program in the South African Public Sector: Cohort Description and Virological Outcomes
por: Moorhouse, Michelle, et al.
Publicado: (2019)

A Clinical Prediction Rule for Protease Inhibitor Resistance in Patients Failing Second-Line Antiretroviral Therapy
por: Cohe, Karen, et al.
Publicado: (2019)

High rates of retention and viral suppression in the scale-up of antiretroviral therapy adherence clubs in Cape Town, South Africa
por: Tsondai, Priscilla Ruvimbo, et al.
Publicado: (2017)

Concentration-Response Relationships of Dolutegravir and Efavirenz with Weight Change After Starting Antiretroviral Therapy
por: Griesel, Rulan, et al.
Publicado: (2022)

Life Expectancies of South African Adults Starting Antiretroviral Treatment: Collaborative Analysis of Cohort Studies
por: Johnson, Leigh F., et al.
Publicado: (2013)

The tuberculosis challenge in a rural South African HIV programme
por: Houlihan, Catherine F, et al.
Publicado: (2010)

‘Covering the tail’ after stopping efavirenz-based antiretroviral therapy
por: Maartens, Gary
Publicado: (2020)

Outcomes of a model integrating tuberculosis testing into COVID-19 services in South Africa
por: Mutyambizi, Chipo, et al.
Publicado: (2022)

Southern African HIV Clinicians Society adult antiretroviral therapy guidelines: Update on when to initiate antiretroviral therapy
por: Meintjes, Graeme, et al.
Publicado: (2015)

Cost-Effectiveness of Highly Active Antiretroviral Therapy in South Africa
por: Badri, Motasim, et al.
Publicado: (2006)

Association of Age with Mortality and Virological and Immunological Response to Antiretroviral Therapy in Rural South African Adults
por: Mutevedzi, Portia C., et al.
Publicado: (2011)

Comparison of six methods to estimate adherence in an ART-naïve cohort in a resource-poor setting: which best predicts virological and resistance outcomes?
por: Orrell, Catherine, et al.
Publicado: (2017)

Quality of life and the impact of drug toxicities in a South African community-based antiretroviral programme
por: Pitt, Jennifer, et al.
Publicado: (2009)

The Impact of HIV, an Antiretroviral Programme and Tuberculosis on Mortality in South African Platinum Miners, 1992–2010
por: Lim, Megan S. C., et al.
Publicado: (2012)

Contrasting predictors of poor antiretroviral therapy outcomes in two South African HIV programmes: a cohort study
por: Dahab, Mison, et al.
Publicado: (2010)

Retention in Care of HIV-Infected Children from HIV Test to Start of Antiretroviral Therapy: Systematic Review
por: Mugglin, Catrina, et al.
Publicado: (2013)

Retention in an antiretroviral therapy programme during an era of decreasing drug cost in Limbe, Cameroon
por: Mosoko, Jembia J, et al.
Publicado: (2011)

Routine data underestimates the incidence of first-line antiretroviral drug discontinuations due to adverse drug reactions: Observational study in two South African cohorts
por: de Waal, Reneé, et al.
Publicado: (2018)

Community adherence support improves programme retention in children on antiretroviral treatment: a multicentre cohort study in South Africa
por: Grimwood, Ashraf, et al.
Publicado: (2012)

When to Start Antiretroviral Therapy
por: Jain, Vivek, et al.
Publicado: (2010)

Delays in starting antiretroviral therapy in patients with HIV-associated tuberculosis accessing non-integrated clinical services in a South African township
por: Lawn, Stephen D, et al.
Publicado: (2011)

Correlation of hair and plasma efavirenz concentrations in HIV-positive South Africans
por: Johnston, Jenna, et al.
Publicado: (2019)

CD4 testing after initiation of antiretroviral therapy: Analysis of routine data from the South African HIV programme
por: Lilian, Rivka R., et al.
Publicado: (2020)

Retention and mortality on antiretroviral therapy in sub‐Saharan Africa: collaborative analyses of HIV treatment programmes
por: Haas, Andreas D, et al.
Publicado: (2018)

Low haemoglobin predicts early mortality among adults starting antiretroviral therapy in an HIV care programme in South Africa: a cohort study
por: Russell, Elizabeth C, et al.
Publicado: (2010)

Agreement between physicians and non-physician clinicians in starting antiretroviral therapy in rural Uganda
por: Vasan, Ashwin, et al.
Publicado: (2009)

Anti-Retroviral Therapy Increases the Prevalence of Dyslipidemia in South African HIV-Infected Patients
por: Dave, Joel A., et al.
Publicado: (2016)

Incremental yield and cost of urine Determine TB-LAM and sputum induction in seriously ill adults with HIV
por: Boyles, Tom H., et al.
Publicado: (2018)

Cannot write session to /tmp/vufind_sessions/sess_ehme72hripnpc5j3b15p9l92ks